{
  "subject_code": "BP604T",
  "subject_name": "Biopharmaceutics and Pharmacokinetics",
  "units": {
    "unit_1": {
      "unit_name": "Introduction to Biopharmaceutics and Drug Absorption",
      "topics": [
        "Introduction to Biopharmaceutics",
        "Mechanisms of drug absorption through GIT",
        "Factors influencing drug absorption through GIT",
        "Absorption of drug from Non per oral extra-vascular routes",
        "Drug distribution and protein binding"
      ],
      "mcqs": [
        {
          "question": "What is the primary focus of biopharmaceutics?",
          "options": [
            "Study of drug absorption, distribution, metabolism, and excretion",
            "Study of drug synthesis",
            "Study of drug stability",
            "Study of drug packaging"
          ],
          "correct_answer": "Study of drug absorption, distribution, metabolism, and excretion"
        },
        {
          "question": "Which of these is NOT a mechanism of drug absorption through GIT?",
          "options": [
            "Passive diffusion",
            "Active transport",
            "Facilitated diffusion",
            "Chemical synthesis"
          ],
          "correct_answer": "Chemical synthesis"
        },
        {
          "question": "What is the main factor affecting drug absorption through GIT?",
          "options": [
            "Physicochemical properties of drug",
            "Color of drug",
            "Packaging of drug",
            "Manufacturing process"
          ],
          "correct_answer": "Physicochemical properties of drug"
        },
        {
          "question": "Which of these is NOT a non-oral route of drug administration?",
          "options": [
            "Intravenous",
            "Intramuscular",
            "Subcutaneous",
            "Gastric"
          ],
          "correct_answer": "Gastric"
        },
        {
          "question": "What is apparent volume of distribution?",
          "options": [
            "Theoretical volume required to contain total drug in body",
            "Actual volume of blood in body",
            "Volume of drug solution",
            "Volume of drug container"
          ],
          "correct_answer": "Theoretical volume required to contain total drug in body"
        },
        {
          "question": "Which of these factors does NOT affect protein-drug binding?",
          "options": [
            "Drug concentration",
            "Protein concentration",
            "Drug structure",
            "Drug color"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the clinical significance of protein binding?",
          "options": [
            "Affects drug distribution and elimination",
            "Affects drug color",
            "Affects drug packaging",
            "Affects drug manufacturing"
          ],
          "correct_answer": "Affects drug distribution and elimination"
        },
        {
          "question": "Which of these is NOT a type of protein-drug binding?",
          "options": [
            "Covalent binding",
            "Ionic binding",
            "Hydrogen bonding",
            "Color binding"
          ],
          "correct_answer": "Color binding"
        },
        {
          "question": "What is tissue permeability?",
          "options": [
            "Ability of drug to pass through biological membranes",
            "Color of tissue",
            "Size of tissue",
            "Shape of tissue"
          ],
          "correct_answer": "Ability of drug to pass through biological membranes"
        },
        {
          "question": "Which of these is NOT a factor affecting drug distribution?",
          "options": [
            "Blood flow to tissues",
            "Tissue binding",
            "Membrane permeability",
            "Drug color"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the main purpose of studying drug absorption?",
          "options": [
            "To optimize drug delivery",
            "To change drug color",
            "To modify packaging",
            "To alter manufacturing"
          ],
          "correct_answer": "To optimize drug delivery"
        },
        {
          "question": "Which of these is NOT a characteristic of passive diffusion?",
          "options": [
            "Requires energy",
            "Follows concentration gradient",
            "No carrier needed",
            "Non-saturable"
          ],
          "correct_answer": "Requires energy"
        },
        {
          "question": "What is the main advantage of intravenous route?",
          "options": [
            "100% bioavailability",
            "Easy administration",
            "Self-administration",
            "No side effects"
          ],
          "correct_answer": "100% bioavailability"
        },
        {
          "question": "Which of these is NOT a plasma protein that binds drugs?",
          "options": [
            "Albumin",
            "Globulin",
            "Fibrinogen",
            "Melanin"
          ],
          "correct_answer": "Melanin"
        },
        {
          "question": "What is the significance of high protein binding?",
          "options": [
            "Longer duration of action",
            "Faster absorption",
            "Better taste",
            "Improved color"
          ],
          "correct_answer": "Longer duration of action"
        },
        {
          "question": "Which of these is NOT a factor affecting GIT absorption?",
          "options": [
            "pH of GI tract",
            "Gastric emptying",
            "Food",
            "Drug color"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the main purpose of studying drug distribution?",
          "options": [
            "To understand drug concentration at site of action",
            "To modify drug color",
            "To change packaging",
            "To alter manufacturing"
          ],
          "correct_answer": "To understand drug concentration at site of action"
        },
        {
          "question": "Which of these is NOT a characteristic of active transport?",
          "options": [
            "No energy required",
            "Against concentration gradient",
            "Saturable",
            "Specific"
          ],
          "correct_answer": "No energy required"
        },
        {
          "question": "What is the main advantage of intramuscular route?",
          "options": [
            "Sustained release",
            "100% bioavailability",
            "No pain",
            "No side effects"
          ],
          "correct_answer": "Sustained release"
        },
        {
          "question": "Which of these is NOT a factor affecting tissue distribution?",
          "options": [
            "Blood flow",
            "Tissue binding",
            "Membrane permeability",
            "Drug color"
          ],
          "correct_answer": "Drug color"
        }
      ]
    },
    "unit_2": {
      "unit_name": "Drug Elimination and Bioavailability",
      "topics": [
        "Drug metabolism and metabolic pathways",
        "Renal excretion of drugs",
        "Non-renal routes of drug excretion",
        "Bioavailability and bioequivalence",
        "In-vitro drug dissolution models"
      ],
      "mcqs": [
        {
          "question": "What is the main purpose of drug metabolism?",
          "options": [
            "To make drugs more water soluble for excretion",
            "To change drug color",
            "To improve taste",
            "To modify packaging"
          ],
          "correct_answer": "To make drugs more water soluble for excretion"
        },
        {
          "question": "Which of these is NOT a phase I metabolic reaction?",
          "options": [
            "Glucuronidation",
            "Oxidation",
            "Reduction",
            "Hydrolysis"
          ],
          "correct_answer": "Glucuronidation"
        },
        {
          "question": "What is the main organ responsible for drug metabolism?",
          "options": [
            "Liver",
            "Kidney",
            "Heart",
            "Lung"
          ],
          "correct_answer": "Liver"
        },
        {
          "question": "Which of these is NOT a factor affecting renal excretion?",
          "options": [
            "Drug color",
            "Urine pH",
            "Blood flow to kidneys",
            "Protein binding"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is renal clearance?",
          "options": [
            "Volume of plasma cleared of drug by kidneys per unit time",
            "Color of urine",
            "Size of kidney",
            "Shape of kidney"
          ],
          "correct_answer": "Volume of plasma cleared of drug by kidneys per unit time"
        },
        {
          "question": "Which of these is NOT a non-renal route of excretion?",
          "options": [
            "Renal excretion",
            "Biliary excretion",
            "Pulmonary excretion",
            "Sweat excretion"
          ],
          "correct_answer": "Renal excretion"
        },
        {
          "question": "What is bioavailability?",
          "options": [
            "Fraction of drug reaching systemic circulation",
            "Color of drug",
            "Taste of drug",
            "Size of drug"
          ],
          "correct_answer": "Fraction of drug reaching systemic circulation"
        },
        {
          "question": "What is absolute bioavailability?",
          "options": [
            "Comparison with IV route",
            "Comparison with oral route",
            "Comparison with IM route",
            "Comparison with SC route"
          ],
          "correct_answer": "Comparison with IV route"
        },
        {
          "question": "Which of these is NOT a method to measure bioavailability?",
          "options": [
            "Color measurement",
            "Plasma concentration",
            "Urinary excretion",
            "Pharmacological response"
          ],
          "correct_answer": "Color measurement"
        },
        {
          "question": "What is bioequivalence?",
          "options": [
            "Similar bioavailability of two drug products",
            "Same color of two drugs",
            "Same packaging of two drugs",
            "Same manufacturing process"
          ],
          "correct_answer": "Similar bioavailability of two drug products"
        },
        {
          "question": "Which of these is NOT a dissolution model?",
          "options": [
            "Color model",
            "Rotating basket",
            "Paddle",
            "Flow-through cell"
          ],
          "correct_answer": "Color model"
        },
        {
          "question": "What is IVIVC?",
          "options": [
            "In-vitro in-vivo correlation",
            "Intravenous injection",
            "In-vitro investigation",
            "In-vivo investigation"
          ],
          "correct_answer": "In-vitro in-vivo correlation"
        },
        {
          "question": "Which of these is NOT a method to enhance dissolution?",
          "options": [
            "Change drug color",
            "Particle size reduction",
            "Salt formation",
            "Solid dispersion"
          ],
          "correct_answer": "Change drug color"
        },
        {
          "question": "What is the main purpose of bioequivalence studies?",
          "options": [
            "To ensure therapeutic equivalence",
            "To match drug colors",
            "To match packaging",
            "To match manufacturing"
          ],
          "correct_answer": "To ensure therapeutic equivalence"
        },
        {
          "question": "Which of these is NOT a phase II metabolic reaction?",
          "options": [
            "Oxidation",
            "Glucuronidation",
            "Sulfation",
            "Acetylation"
          ],
          "correct_answer": "Oxidation"
        },
        {
          "question": "What is the main advantage of biliary excretion?",
          "options": [
            "Enterohepatic circulation",
            "Faster excretion",
            "No metabolism",
            "No side effects"
          ],
          "correct_answer": "Enterohepatic circulation"
        },
        {
          "question": "Which of these is NOT a factor affecting bioavailability?",
          "options": [
            "Drug color",
            "First pass metabolism",
            "Formulation factors",
            "Physiological factors"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the main purpose of dissolution testing?",
          "options": [
            "To predict in-vivo performance",
            "To measure color",
            "To test packaging",
            "To check manufacturing"
          ],
          "correct_answer": "To predict in-vivo performance"
        },
        {
          "question": "Which of these is NOT a characteristic of good bioavailability?",
          "options": [
            "High first pass metabolism",
            "Good solubility",
            "Good permeability",
            "Stable in GI tract"
          ],
          "correct_answer": "High first pass metabolism"
        },
        {
          "question": "What is the main advantage of pulmonary excretion?",
          "options": [
            "Rapid elimination of volatile drugs",
            "No metabolism",
            "No side effects",
            "No first pass effect"
          ],
          "correct_answer": "Rapid elimination of volatile drugs"
        }
      ]
    },
    "unit_3": {
      "unit_name": "Pharmacokinetics: Basic Concepts",
      "topics": [
        "Introduction to pharmacokinetics",
        "Compartment models",
        "One compartment open model",
        "Pharmacokinetic parameters",
        "Methods of elimination"
      ],
      "mcqs": [
        {
          "question": "What is pharmacokinetics?",
          "options": [
            "Study of drug movement in body",
            "Study of drug synthesis",
            "Study of drug color",
            "Study of drug packaging"
          ],
          "correct_answer": "Study of drug movement in body"
        },
        {
          "question": "Which of these is NOT a compartment model?",
          "options": [
            "Color model",
            "One compartment",
            "Two compartment",
            "Multi-compartment"
          ],
          "correct_answer": "Color model"
        },
        {
          "question": "What is elimination rate constant (Ke)?",
          "options": [
            "Fraction of drug eliminated per unit time",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Fraction of drug eliminated per unit time"
        },
        {
          "question": "What is half-life (t1/2)?",
          "options": [
            "Time for drug concentration to reduce by half",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Time for drug concentration to reduce by half"
        },
        {
          "question": "What is volume of distribution (Vd)?",
          "options": [
            "Apparent volume to contain total drug",
            "Actual blood volume",
            "Color of drug",
            "Size of drug"
          ],
          "correct_answer": "Apparent volume to contain total drug"
        },
        {
          "question": "What is AUC?",
          "options": [
            "Area under concentration-time curve",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Area under concentration-time curve"
        },
        {
          "question": "What is absorption rate constant (Ka)?",
          "options": [
            "Rate of drug absorption",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Rate of drug absorption"
        },
        {
          "question": "What is total clearance (Clt)?",
          "options": [
            "Volume of plasma cleared per unit time",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Volume of plasma cleared per unit time"
        },
        {
          "question": "What is renal clearance (Clr)?",
          "options": [
            "Volume of plasma cleared by kidneys per unit time",
            "Color of drug",
            "Size of drug",
            "Shape of drug"
          ],
          "correct_answer": "Volume of plasma cleared by kidneys per unit time"
        },
        {
          "question": "Which of these is NOT a method of elimination?",
          "options": [
            "Color elimination",
            "Renal excretion",
            "Metabolism",
            "Biliary excretion"
          ],
          "correct_answer": "Color elimination"
        },
        {
          "question": "What is the main advantage of one compartment model?",
          "options": [
            "Simplicity",
            "Accuracy",
            "Color prediction",
            "Size prediction"
          ],
          "correct_answer": "Simplicity"
        },
        {
          "question": "Which of these is NOT a pharmacokinetic parameter?",
          "options": [
            "Drug color",
            "Half-life",
            "Clearance",
            "Volume of distribution"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the significance of AUC?",
          "options": [
            "Total drug exposure",
            "Drug color",
            "Drug size",
            "Drug shape"
          ],
          "correct_answer": "Total drug exposure"
        },
        {
          "question": "Which of these is NOT a characteristic of first order kinetics?",
          "options": [
            "Constant amount eliminated",
            "Constant fraction eliminated",
            "Exponential decay",
            "Half-life independent of dose"
          ],
          "correct_answer": "Constant amount eliminated"
        },
        {
          "question": "What is the main purpose of pharmacokinetic studies?",
          "options": [
            "To optimize drug dosing",
            "To change drug color",
            "To modify packaging",
            "To alter manufacturing"
          ],
          "correct_answer": "To optimize drug dosing"
        },
        {
          "question": "Which of these is NOT a factor affecting clearance?",
          "options": [
            "Drug color",
            "Blood flow",
            "Protein binding",
            "Enzyme activity"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the significance of volume of distribution?",
          "options": [
            "Indicates drug distribution in body",
            "Indicates drug color",
            "Indicates drug size",
            "Indicates drug shape"
          ],
          "correct_answer": "Indicates drug distribution in body"
        },
        {
          "question": "Which of these is NOT a characteristic of zero order kinetics?",
          "options": [
            "Constant fraction eliminated",
            "Constant amount eliminated",
            "Linear decay",
            "Half-life dependent on dose"
          ],
          "correct_answer": "Constant fraction eliminated"
        },
        {
          "question": "What is the main advantage of clearance concept?",
          "options": [
            "Independent of volume of distribution",
            "Indicates color",
            "Indicates size",
            "Indicates shape"
          ],
          "correct_answer": "Independent of volume of distribution"
        },
        {
          "question": "Which of these is NOT a use of pharmacokinetic parameters?",
          "options": [
            "To determine drug color",
            "To calculate dosing regimen",
            "To predict drug interactions",
            "To optimize therapy"
          ],
          "correct_answer": "To determine drug color"
        }
      ]
    },
    "unit_4": {
      "unit_name": "Multicompartment Models and Multiple Dosing",
      "topics": [
        "Two compartment open model",
        "IV bolus kinetics",
        "Multiple dosing kinetics",
        "Steady state drug levels",
        "Loading and maintenance doses"
      ],
      "mcqs": [
        {
          "question": "What is the main advantage of two compartment model?",
          "options": [
            "More accurate for many drugs",
            "Simpler calculations",
            "Better color prediction",
            "Better size prediction"
          ],
          "correct_answer": "More accurate for many drugs"
        },
        {
          "question": "What is distribution phase in two compartment model?",
          "options": [
            "Initial rapid decline in plasma concentration",
            "Color change",
            "Size change",
            "Shape change"
          ],
          "correct_answer": "Initial rapid decline in plasma concentration"
        },
        {
          "question": "What is elimination phase in two compartment model?",
          "options": [
            "Slower decline in plasma concentration",
            "Color change",
            "Size change",
            "Shape change"
          ],
          "correct_answer": "Slower decline in plasma concentration"
        },
        {
          "question": "What is steady state?",
          "options": [
            "When drug input equals output",
            "When color is stable",
            "When size is stable",
            "When shape is stable"
          ],
          "correct_answer": "When drug input equals output"
        },
        {
          "question": "What is loading dose?",
          "options": [
            "Initial dose to reach steady state quickly",
            "Color dose",
            "Size dose",
            "Shape dose"
          ],
          "correct_answer": "Initial dose to reach steady state quickly"
        },
        {
          "question": "What is maintenance dose?",
          "options": [
            "Dose to maintain steady state",
            "Color dose",
            "Size dose",
            "Shape dose"
          ],
          "correct_answer": "Dose to maintain steady state"
        },
        {
          "question": "Which of these is NOT a characteristic of multiple dosing?",
          "options": [
            "Color accumulation",
            "Drug accumulation",
            "Fluctuation in levels",
            "Steady state achievement"
          ],
          "correct_answer": "Color accumulation"
        },
        {
          "question": "What is accumulation factor?",
          "options": [
            "Ratio of steady state to single dose levels",
            "Color ratio",
            "Size ratio",
            "Shape ratio"
          ],
          "correct_answer": "Ratio of steady state to single dose levels"
        },
        {
          "question": "What is the main advantage of loading dose?",
          "correct_answer": "Quick achievement of therapeutic levels"
        },
        {
          "question": "Which of these is NOT a factor affecting steady state?",
          "options": [
            "Drug color",
            "Dosing interval",
            "Half-life",
            "Dose"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the significance of two compartment model?",
          "options": [
            "Better prediction of drug behavior",
            "Better color prediction",
            "Better size prediction",
            "Better shape prediction"
          ],
          "correct_answer": "Better prediction of drug behavior"
        },
        {
          "question": "Which of these is NOT a parameter in two compartment model?",
          "options": [
            "Color constant",
            "Distribution rate constant",
            "Elimination rate constant",
            "Volume of central compartment"
          ],
          "correct_answer": "Color constant"
        },
        {
          "question": "What is the main purpose of multiple dosing?",
          "options": [
            "To maintain therapeutic levels",
            "To change color",
            "To modify size",
            "To alter shape"
          ],
          "correct_answer": "To maintain therapeutic levels"
        },
        {
          "question": "Which of these is NOT a characteristic of steady state?",
          "options": [
            "Color stability",
            "Constant average levels",
            "Peak and trough levels",
            "Dose-dependent levels"
          ],
          "correct_answer": "Color stability"
        },
        {
          "question": "What is the main advantage of maintenance dose?",
          "options": [
            "Maintains therapeutic levels",
            "Changes color",
            "Modifies size",
            "Alters shape"
          ],
          "correct_answer": "Maintains therapeutic levels"
        },
        {
          "question": "Which of these is NOT a factor in loading dose calculation?",
          "options": [
            "Drug color",
            "Volume of distribution",
            "Target concentration",
            "Bioavailability"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the significance of fluctuation?",
          "options": [
            "Indicates variation in drug levels",
            "Indicates color change",
            "Indicates size change",
            "Indicates shape change"
          ],
          "correct_answer": "Indicates variation in drug levels"
        },
        {
          "question": "Which of these is NOT a characteristic of IV bolus?",
          "options": [
            "Color change",
            "Rapid distribution",
            "Two phase decline",
            "Complete bioavailability"
          ],
          "correct_answer": "Color change"
        },
        {
          "question": "What is the main advantage of steady state?",
          "options": [
            "Predictable drug levels",
            "Color stability",
            "Size stability",
            "Shape stability"
          ],
          "correct_answer": "Predictable drug levels"
        },
        {
          "question": "Which of these is NOT a use of two compartment model?",
          "options": [
            "Color prediction",
            "Dose calculation",
            "Drug interaction prediction",
            "Therapy optimization"
          ],
          "correct_answer": "Color prediction"
        }
      ]
    },
    "unit_5": {
      "unit_name": "Nonlinear Pharmacokinetics",
      "topics": [
        "Introduction to nonlinear pharmacokinetics",
        "Factors causing nonlinearity",
        "Michaelis-Menten kinetics",
        "Parameter estimation",
        "Examples of nonlinear drugs"
      ],
      "mcqs": [
        {
          "question": "What is nonlinear pharmacokinetics?",
          "options": [
            "When pharmacokinetic parameters change with dose",
            "When color changes with dose",
            "When size changes with dose",
            "When shape changes with dose"
          ],
          "correct_answer": "When pharmacokinetic parameters change with dose"
        },
        {
          "question": "Which of these is NOT a factor causing nonlinearity?",
          "options": [
            "Drug color",
            "Enzyme saturation",
            "Protein binding saturation",
            "Absorption saturation"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is Michaelis-Menten equation?",
          "options": [
            "Describes enzyme kinetics",
            "Describes color change",
            "Describes size change",
            "Describes shape change"
          ],
          "correct_answer": "Describes enzyme kinetics"
        },
        {
          "question": "What is Vmax in Michaelis-Menten kinetics?",
          "options": [
            "Maximum rate of reaction",
            "Maximum color",
            "Maximum size",
            "Maximum shape"
          ],
          "correct_answer": "Maximum rate of reaction"
        },
        {
          "question": "What is Km in Michaelis-Menten kinetics?",
          "options": [
            "Substrate concentration at half Vmax",
            "Color at half maximum",
            "Size at half maximum",
            "Shape at half maximum"
          ],
          "correct_answer": "Substrate concentration at half Vmax"
        },
        {
          "question": "Which of these is NOT an example of nonlinear drug?",
          "options": [
            "Water",
            "Phenytoin",
            "Ethanol",
            "Aspirin"
          ],
          "correct_answer": "Water"
        },
        {
          "question": "What is the main advantage of Michaelis-Menten kinetics?",
          "options": [
            "Describes enzyme saturation",
            "Describes color change",
            "Describes size change",
            "Describes shape change"
          ],
          "correct_answer": "Describes enzyme saturation"
        },
        {
          "question": "Which of these is NOT a characteristic of nonlinear kinetics?",
          "options": [
            "Color changes with dose",
            "Half-life changes with dose",
            "Clearance changes with dose",
            "AUC not proportional to dose"
          ],
          "correct_answer": "Color changes with dose"
        },
        {
          "question": "What is the main purpose of studying nonlinear kinetics?",
          "options": [
            "To optimize dosing of nonlinear drugs",
            "To change drug color",
            "To modify packaging",
            "To alter manufacturing"
          ],
          "correct_answer": "To optimize dosing of nonlinear drugs"
        },
        {
          "question": "Which of these is NOT a method to estimate Michaelis-Menten parameters?",
          "options": [
            "Color measurement",
            "Lineweaver-Burk plot",
            "Eadie-Hofstee plot",
            "Direct linear plot"
          ],
          "correct_answer": "Color measurement"
        },
        {
          "question": "What is the significance of enzyme saturation?",
          "options": [
            "Causes nonlinear kinetics",
            "Changes color",
            "Changes size",
            "Changes shape"
          ],
          "correct_answer": "Causes nonlinear kinetics"
        },
        {
          "question": "Which of these is NOT a characteristic of phenytoin kinetics?",
          "options": [
            "Color changes with dose",
            "Nonlinear absorption",
            "Nonlinear metabolism",
            "Narrow therapeutic index"
          ],
          "correct_answer": "Color changes with dose"
        },
        {
          "question": "What is the main advantage of Lineweaver-Burk plot?",
          "options": [
            "Easy estimation of Vmax and Km",
            "Color prediction",
            "Size prediction",
            "Shape prediction"
          ],
          "correct_answer": "Easy estimation of Vmax and Km"
        },
        {
          "question": "Which of these is NOT a factor in nonlinear absorption?",
          "options": [
            "Drug color",
            "Carrier saturation",
            "Poor solubility",
            "Formulation factors"
          ],
          "correct_answer": "Drug color"
        },
        {
          "question": "What is the main advantage of Eadie-Hofstee plot?",
          "options": [
            "Better error distribution",
            "Better color prediction",
            "Better size prediction",
            "Better shape prediction"
          ],
          "correct_answer": "Better error distribution"
        },
        {
          "question": "Which of these is NOT a characteristic of ethanol kinetics?",
          "options": [
            "Color changes with dose",
            "Zero order at high doses",
            "First order at low doses",
            "Enzyme saturation"
          ],
          "correct_answer": "Color changes with dose"
        },
        {
          "question": "What is the significance of protein binding saturation?",
          "options": [
            "Causes nonlinear distribution",
            "Changes color",
            "Changes size",
            "Changes shape"
          ],
          "correct_answer": "Causes nonlinear distribution"
        },
        {
          "question": "Which of these is NOT a characteristic of aspirin kinetics?",
          "options": [
            "Color changes with dose",
            "Nonlinear protein binding",
            "Nonlinear metabolism",
            "Dose-dependent half-life"
          ],
          "correct_answer": "Color changes with dose"
        },
        {
          "question": "What is the main advantage of direct linear plot?",
          "options": [
            "No transformation of data",
            "Better color prediction",
            "Better size prediction",
            "Better shape prediction"
          ],
          "correct_answer": "No transformation of data"
        },
        {
          "question": "Which of these is NOT a use of nonlinear kinetics?",
          "options": [
            "Color prediction",
            "Dose optimization",
            "Drug interaction prediction",
            "Therapy individualization"
          ],
          "correct_answer": "Color prediction"
        }
      ]
    }
  }
} 